|1.||Basler, Christopher F: 2 articles (07/2013 - 07/2003)|
|2.||Yen, Benjamin: 1 article (07/2013)|
|3.||Ebihara, Hideki: 1 article (07/2013)|
|4.||Tsuda, Yoshimi: 1 article (07/2013)|
|5.||Weisend, Carla: 1 article (07/2013)|
|6.||Ramanan, Parameshwaran: 1 article (07/2013)|
|7.||Amarasinghe, Gaya K: 1 article (07/2013)|
|8.||Geisbert, Thomas W: 1 article (07/2013)|
|9.||Liu, Gai: 1 article (07/2013)|
|10.||Mire, Chad E: 1 article (07/2013)|
|1.||Human Influenza (Influenza)
10/24/2000 - "When plasmids expressing individual Ebola virus proteins were transfected into Madin Darby canine kidney cells, the Ebola virus VP35 protein enhanced influenza delNS1 virus growth more than 100-fold. "
07/01/2003 - "The Ebola virus VP35 protein was previously found to act as an interferon (IFN) antagonist which could complement growth of influenza delNS1 virus, a mutant influenza virus lacking the influenza virus IFN antagonist protein, NS1. "
02/01/2010 - "When expressed in mouse immature DCs, Ebola virus VP35 prevents virus-stimulated expression of CD40, CD80, CD86 and major histocompatibility complex class II. Further, it suppresses the induction of cytokines such as interleukin (IL)-6, IL-12, tumour necrosis factor alpha and alpha/beta interferon (IFN-alpha/beta). "
|1.||Interleukin-12 (IL 12)
|4.||Proteins (Proteins, Gene)
|7.||Complement System Proteins (Complement)